Maximum amplitude (mV) of reproducible motor evoked potentials (MEP) in relation to stimulation site 1, 2, and 3 | ||||||
---|---|---|---|---|---|---|
stimulation site | ||||||
N | Age (y)/sex | Tumour | Location | 1: 2.5 cm behind bregma (SMA) | 2: 2 cm behind stimulation site 1 (precentral gyrus) | 3: 4 cm behind stimulation site 1 (postcentral gyrus) |
1 | 59/M | meningioma | frontal | 0.39 mV | 0.38 mV | 0.07 mV |
2 | 54/M | glioma | parietal | 0.20 mV | 0.50 mV | 0.44 mV |
3 | 64/M | glioma | frontal | 0.28 mV | 3.89 mV | 0.30 mV |
4 | 26/M | glioma | frontal | 0.03 mV | 0.20 mV | 0.07 mV |
5 | 75/F | metastasis | parietal | 0.43 mV | 1.14 mV | 0.56 mV |
6 | 77/M | meningioma | parietal | no CMAP | 6.12 mV | 5.45 mV |
7 | 49/F | meningioma | parietal | no CMAP | 3.33 mV | no CMAP |
8 | 39/M | glioma | frontal | 0.01 mV | 5.27 mV | no CMAP |
9 | 52/F | meningioma | frontal | minimal signal | 0.17 mV | no CMAP |
10 | 32/M | glioma | frontal | no CMAP | minimal signal | no CMAP |
11 | 39/F | glioma | frontal | no CMAP | 0.9 mV | no CMAP |
12 | 61/M | glioma | frontal | no CMAP | 0.05 mV | no CMAP |